CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,290,587
+$3,479,413 QoQ
Shares Held
1,008,107
+1.5% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 177 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. MRVI ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,290,587 | 1,008,107 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,811,174 | 993,348 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,211,130 | 988,040 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,837,537 | 988,689 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,243,413 | 930,877 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,101,150 | 950,747 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,940,365 | 906,489 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,866,046 | 946,576 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,376,015 | 890,505 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,570,154 | 642,463 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,685,514 | 562,674 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,101,860 | 610,186 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,274,769 | 585,259 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,104,154 | 578,455 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,305,652 | 580,409 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,470,582 | 566,807 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,771,161 | 590,326 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $21,273,841 | 603,171 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $24,655,594 | 588,439 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $28,231,404 | 575,212 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,754,439 | 473,387 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,890,194 | 305,561 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||